Hyperlipoproteinemia Type 4
Symptoms, Doctors, Treatments, Advances & More

Hyperlipoproteinemia Type 4 Overview

Save information for later
Sign Up

Learn About Hyperlipoproteinemia Type 4

What is the definition of Hyperlipoproteinemia Type 4?
Hyperlipoproteinemia Type IV, also known as carbohydrate-inducible hyperlipemia, is a condition in which an individual has high levels of very low-density lipoprotein (LDL) cholesterol and triglycerides (types of fat) in their blood. High levels of very low-density lipoprotein cholesterol and triglycerides can cause atherosclerosis, or the build-up of plaques of fatty cholesterol in the artery walls, which can lead to heart disease or stroke. Hyperlipoproteinemia Type IV is believed to occur in individuals who have a genetic predisposition for the disease and from consuming carbohydrates and alcohol.
What are the symptoms of Hyperlipoproteinemia Type 4?
Hyperlipoproteinemia may not cause any symptoms or may cause hypertriglyceridemic waist, which is an elevated waist circumference (>90 cm in men or >85 cm in women).
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Hyperlipoproteinemia Type 4?
Treatment for hyperlipoproteinemia Type IV includes the use of metformin, a medication that lowers blood glucose (sugar); atorvastatin, a drug that lowers blood cholesterol levels; and chenodeoxycholic acid, a bile acid that lowers the production of cholesterol in the liver and its absorption in the small intestine.
Who are the top Hyperlipoproteinemia Type 4 Local Doctors?
Distinguished in Hyperlipoproteinemia Type 4
Dr. Keith W. Harrison
Family Medicine
Distinguished in Hyperlipoproteinemia Type 4
Dr. Keith W. Harrison
Family Medicine

Boyertown Medical Associates

23 N Walnut St, 
Boyertown, PA 
610-367-2259
Languages Spoken:
English
See accepted insurances

Keith Harrison is a primary care provider, practicing in Family Medicine in Boyertown, Pennsylvania. Dr. Harrison is rated as a Distinguished provider by MediFind in the treatment of Hyperlipoproteinemia Type 4. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Hyperlipoproteinemia Type 4, Heterozygous Familial Hypercholesterolemia (HeFH), Homozygous Familial Hypercholesterolemia (HoFH), and Familial Hypercholesterolemia. Dr. Harrison is board certified in American Board Of Family Medicine.

Advanced in Hyperlipoproteinemia Type 4
Dr. Paul P. Doghramji
Family Medicine
Advanced in Hyperlipoproteinemia Type 4
Dr. Paul P. Doghramji
Family Medicine

Collegeville Family Practice

555 Second Ave, Ste 300, 
Collegeville, PA 
610-454-7750
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Paul Doghramji is a primary care provider, practicing in Family Medicine in Collegeville, Pennsylvania. Dr. Doghramji is rated as an Advanced provider by MediFind in the treatment of Hyperlipoproteinemia Type 4. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Insomnia, Gout, Obesity, and High Cholesterol. Dr. Doghramji is board certified in American Board Of Family Medicine.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Hyperlipoproteinemia Type 4
Dr. Nahid Sultana
Family Medicine
Advanced in Hyperlipoproteinemia Type 4
Dr. Nahid Sultana
Family Medicine

Brookside Family Practice & Pediatrics

1555 Medical Dr, 
Pottstown, PA 
610-326-7820
Languages Spoken:
English
See accepted insurances

Nahid Sultana is a primary care provider, practicing in Family Medicine in Pottstown, Pennsylvania. Dr. Sultana is rated as an Advanced provider by MediFind in the treatment of Hyperlipoproteinemia Type 4. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses High Cholesterol, Obesity, Hypertension, and Familial Hypertension. Dr. Sultana is board certified in American Board Of Family Medicine.

View All Doctors
What are the latest Hyperlipoproteinemia Type 4 Clinical Trials?
A Multi-center, Open Label, Multi-arm, Dose Ascending Clinical Trial for Evaluation of Safety and Tolerance of Gene Therapy Drug GC304 in the Treatment of Primary Hypertriglyceridemia Patients With History of Acute Pancreatitis
A Multi-center, Open Label, Multi-arm, Dose Ascending Clinical Trial for Evaluation of Safety and Tolerance of Gene Therapy Drug GC304 in the Treatment of Primary Hypertriglyceridemia Patients With History of Acute Pancreatitis
Enrollment Status: Recruiting
Publish Date: July 03, 2025
Intervention Type: Genetic
Study Phase: Phase 1

Summary: The study will evaluate safety and tolerance of intravenous delivery of GC304 gene therapy drug as a treatment of primary hypertriglyceridemic patients with previous onset of acute pancreatitis.

Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials